(Q38261580)

1 September 2017

1 reference

title

Pembrolizumab: first global approval (English)

1 reference

1 September 2017

1 reference

Raewyn M Poole

1

1 reference

1 September 2017

publication date

1 October 2014

1 reference

1 September 2017

1 reference

1 September 2017

volume

74

1 reference

1 September 2017

issue

16

1 reference

1 September 2017

page(s)

1973-1981

1 reference

https://scigraph.springernature.com/pub.10.1007/s40265-014-0314-5

1 September 2017

exact match

0 references

cites work

Biomarkers for immunostimulatory monoclonal antibodies in combination strategies for melanoma and other tumor types

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0314-5

Targeting the PD-1 pathway: a promising future for the treatment of melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0314-5

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0314-5

A review of novel therapies for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0314-5

Programmed death 1 pathway inhibition in metastatic renal cell cancer and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0314-5

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0314-5

Update on immune checkpoint inhibitors in lung cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25331768

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Immune checkpoint inhibitors in NSCLC.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25331768

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S40265-014-0314-5

1 reference

Dimensions Publication ID

1 September 2017

1030107897

0 references

1 reference